Mann Eye Institute Celebrates 47 Years of Transforming Lives Through Vision

September 18, 2024 11:30 AM

HOUSTON, TX / ACCESSWIRE / September 18, 2024 / Mann Eye Institute, a leading provider of comprehensive eye care services in Texas, is proud to announce its 47th anniversary. Founded on October 31, 1977, by Dr. Mike Mann, the institute has grown from a single location with four employees to a network of 17 state-of-the-art facilities employing 500 dedicated professionals across the state."For nearly five decades, Mann Eye Institute has been at...

Read more

Environmental Protection Agency Honors MilliporeSigma With a 2024 Green Power Leadership Award

September 18, 2024 11:00 AM

NORTHAMPTON, MA / ACCESSWIRE / September 18, 2024 / MilliporeSigmaMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has won a 2024 Green Power Leadership Award from the United States Environmental Protection Agency. The company was honored for its commitment to renewable energy and advancing the green power market nationwide through innovative and impactful initiatives supporting sustainable...

Read more

Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator

September 18, 2024 10:15 AM

ALLEN, TX / ACCESSWIRE / September 18, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, represented by Professor Tchorbanov PhD, Head of the Department of Immunology and Penka Petrova PHD, DSc, Director of the Institute of Microbiology, has issued its first report under the recently announced collaborative...

Read more

Ready Doc(R) Rebrands to 'Incredable(TM)' With New Logo and Brand Identity After Revolutionizing Credentialing

September 18, 2024 10:00 AM

The rebrand reinforces the company's commitment to simplifying healthcare administration and streamlining credentialing to help providers focus on patient care.AUSTIN, TX / ACCESSWIRE / September 18, 2024 / Ready Doc®, a leader in healthcare credentialing solutions and a subsidiary of Intiva Health, is excited to announce its official rebrand to "Incredable™," a name that reflects the company's evolution and commitment to redefining the...

Read more

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

September 18, 2024 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price...

Read more

Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

September 18, 2024 8:00 AM

REDWOOD CITY, CA / ACCESSWIRE / September 18, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the issuance of a new U.S. patent and the allowance of five additional U.S. patents that are expected to issue over the next four months. These patents expand intellectual property...

Read more

Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology

September 18, 2024 8:00 AM

Allowed claims cover major features of pumping mechanism in FDA-cleared MODD1 productSAN DIEGO, CA / ACCESSWIRE / September 18, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" thanks to its user-friendly and affordable design, announced the issuance of U.S. Divisional Patent...

Read more

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

September 18, 2024 7:30 AM

CHATHAM, NJ / ACCESSWIRE / September 18, 2024 / The mpox virus, formerly known as monkeypox, has increasingly become a global health concern, especially with rising cases of a new lethal strain across Africa and parts of Europe and Asia. In response to the spread of this dangerous disease, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) and highlighted an urgent need for a single-dose mpox...

Read more

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025

September 18, 2024 7:00 AM

MIAMI, FL / ACCESSWIRE / September 18, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing innovative therapies for neurologic and neuropsychiatric disorders, today announced significant progress in the clinical development planning for its novel oral ketamine analog. As part of its strategic development plan, MIRA is prioritizing the early demonstration of clinical efficacy,...

Read more

Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus

September 18, 2024 6:00 AM

Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has launched a new addition to its robust product portfolio, OsteoVive Plus, a moldable, viable bone matrix that can be used in a variety of grafting procedures. The graft is now available, to the company's nationwide distribution network of independent agents as well as...

Read more

Bioz Stars Revolutionizes Product Selection in Scientific Research With Objective Ratings

September 18, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / September 18, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, proudly highlights the exceptional value of Bioz Stars, a patented industry standard rating system that has made product selection in the scientific community more efficient and effective. As an objective data-driven rating system, Bioz Stars empowers scientists to make informed choices with confidence.Bioz Stars Ratings: Data-Driven Rating...

Read more

Global Aquaculture Immunostimulants Market Set to Reach USD 193.2 Million by 2034, Driven by 6.4% CAGR | Future Market Insights, Inc.

September 18, 2024 3:50 AM

The global aquaculture immunostimulants market is on a steady growth trajectory, with projected sales expected to reach USD 193.2 million by 2034, up from an estimated USD 103.7 million in 2024. This marks a compound annual growth rate (CAGR) of 6.4% over the forecast period from 2024 to 2034.Aquaculture immunostimulants are gaining widespread attention as the industry increasingly shifts towards sustainable and disease-resistant aquaculture...

Read more

A Visionary Approach to Pet Care: Dr. Jaime Klimsey Pickett

September 18, 2024 3:00 AM

Dr. Jaime Klimsey Pickett, a distinguished leader in veterinary medicine and accomplished entrepreneur, continues to make significant strides in advancing animal welfare through her role as CEO, President, and Board Member of Hannah Pet Hospitals. Her journey from a passionate animal lover to a trailblazing executive underscores her dedication to fostering a supportive and innovative workplace while ensuring the highest standards of veterinary...

Read more

IRLAB Granted Additional Patent for its Drug Candidate Pirepemat Expanding the Patent Protection in the US

September 18, 2024 1:20 AM

GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 18, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that a new patent has been granted in the US covering a salt of the drug candidate pirepemat. The patent covers the active pharmaceutical ingredient used in the...

Read more

Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024

September 18, 2024 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that it has completed dosing in its proof-of-concept clinical study of RLF-OD032 for the treatment of phenylketonuria (PKU), a rare inherited disorder affecting phenylalanine metabolism. The primary objectives...

Read more

Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

September 17, 2024 5:15 PM

Dermata raises approximately $7.8 million in gross proceeds since May 2024 - expected to fund its operations into the second quarter of 2025SAN DIEGO, CA / ACCESSWIRE / September 17, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the closing of its previously announced...

Read more

NCQA Unveils 2024 Health Plan Ratings

September 17, 2024 4:50 PM

5 Health Plans Achieve a 5-Star RatingWASHINGTON, D.C. / ACCESSWIRE / September 17, 2024 / The National Committee for Quality Assurance (NCQA) today announced its 2024 Health Plan Ratings, an annual list that evaluates commercial, Medicare and Medicaid health plans based on assessments of patient experience and clinical quality. The 2024 Health Plan Ratings are based on data from calendar year 2023, when approximately 227 million people were...

Read more

Epica International, Inc. Secures $18 Million Growth Capital Credit Facility From Avenue Capital Group to Drive Innovation and Expansion

September 17, 2024 4:50 PM

LANDRUM, S.C. / ACCESSWIRE / September 17, 2024 / Epica International Inc., a global leader in advanced medical imaging and precision robotics, today announced the closing of an $18 million growth capital credit facility with [Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P., which are funds of] Avenue Capital Group. The initial funding of $13.5 million will be used to refinance existing debt, support...

Read more

MD Clarity Unveils Major Expansion of Its Contract Modeling Module to Empower Providers in Payer Negotiations

September 17, 2024 1:00 PM

SEATTLE, WA / ACCESSWIRE / September 17, 2024 / MD Clarity, a leading provider of revenue optimization software, today announced the launch of a major expansion of its contract modeling module. This offering empowers healthcare providers to proactively model the financial impact of proposed payer contract changes, facilitating optimal reimbursement and revenue capture. The complexities of payer contracts and the pressure to act quickly often...

Read more

Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price

September 17, 2024 11:45 AM

CHICAGO, IL / ACCESSWIRE / September 17, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that on September 16, 2024, Taglich Brothers, Inc. ("Taglich Brothers")...

Read more